Clinical Trial Confidentiality Agreement

This Clinical Trial Confidentiality Agreement ("Agreement") is made and entered into as of the date below, by and between:

Disclosing Party:

Receiving Party:

Effective Date:

1. Definition of Confidential Information

For the purposes of this Agreement, "Confidential Information" refers to all written, electronic, or oral information disclosed by the Disclosing Party to the Receiving Party relating to the clinical trial, including but not limited to protocols, data, results, reports, and any other proprietary or sensitive information.

2. Obligations of Confidentiality

• The Receiving Party agrees to keep all Confidential Information strictly confidential.
• The Receiving Party shall not disclose Confidential Information to any third party without the prior written consent of the Disclosing Party.
• The Receiving Party shall use the Confidential Information solely for the purpose of participating in the clinical trial.

3. Exclusions

Confidential Information does not include information that:

• Was already known to the Receiving Party prior to disclosure;
• Is or becomes publicly available through no fault of the Receiving Party;
• Is disclosed to the Receiving Party by a third party without breach of any obligation of confidentiality; or
• Is independently developed by the Receiving Party without reference to the Confidential Information.

4. Term

This Agreement shall remain in effect for a period of years from the Effective Date or until such time as all Confidential Information lawfully becomes public knowledge, whichever occurs first.

5. Return of Information

Upon termination of this Agreement or upon request by the Disclosing Party, the Receiving Party shall promptly return or destroy all Confidential Information.

6. Governing Law

This Agreement shall be governed by and construed in accordance with the laws of .